期刊文献+

环糊精与三种药物包合过程的量子化学研究

A Quantum-mechanical Study on the Complexation of β-cyclodextrin with Three Drugs
下载PDF
导出
摘要 采用密度泛函理论和半经验方法对幽门螺旋杆菌根除剂、乃富利、2-羟基-5-甲氧基苯乙酮三种药物分子与β-环糊精进行包合的整个过程进行量子化学研究.其结果表明,幽门螺旋杆菌根除剂分子与β-环糊精形成的小口端模型(从窄端进入)比大口端模型(从阔端进入)更为稳定,乃富利分子与β-环糊精形成的大口端模型(从阔端进入)比小口端模型(从窄端进入)更为稳定,而2-羟基-5-甲氧基苯乙酮与β-环糊精的形成的大口端模型(从阔端进入)要比小口端模型(从窄端进入)所形成的包合物更为稳定.包合过程的计算结果与其所对应的实验结论一致. The paper applied the quantum chemistry mothods and systematically studied on the inclusion processes of three drugs (Helicobacter Pylori Eradicating Agent, niflumic acid, 2′-hydroxyl-5′-methoxyacetophone) withβ-cyclodextrin. The results indicate that the inclusion complex formed by Helicobacter Pylori Eradicating Agent en-tering into the cavity ofβ-CD from its narrow side(the primary hydroxyl group side)is more stable than that formed by Helicobacter Pylori Eradicating Agent entering into the cavity ofβ-CD from its wide side(the secondary hydroxyl group side). The inclusion complex formed by niflumic acid entering into the cavity ofβ-CD from its wide side(the secondary hydroxyl group side)is more stable than that formed by niflumic acid entering into the cavity ofβ-CD from its narrow side(the primary hydroxyl group side). The inclusion complex formed by 2′-hydroxyl-5′-methoxyaceto-phone entering into the cavity ofβ-CD from its wide side(the secondary hydroxyl group side)is more stable than that formed by 2′-hydroxyl-5′-methoxyacetophone entering into the cavity ofβ-CD from its narrow side(the primary hydroxyl group side). The molecular modeling results are in good agreement with the corresponding experimental.
作者 金鑫
出处 《内蒙古民族大学学报(自然科学版)》 2013年第5期517-521,共5页 Journal of Inner Mongolia Minzu University:Natural Sciences
关键词 环糊精 密度泛函理论 包合物 电荷转移 Cyclodextrin Density functional theory(DFT) Inclusion complex Charge transfer
  • 相关文献

参考文献16

  • 1Szejtli J. Introduction and General Overview of cyclodextrin chemistry[J].{H}CHEMICAL REVIEWS,1998,(05):1743-1754.
  • 2Rekharsky M V,Inoue Y. Complexation Thermodynamics of Cyclodextrins[J].{H}CHEMICAL REVIEWS,1998.1875-1918.
  • 3Lipkowitz K B. Applications of computational chemistry to the study of cyclodextrins[J].{H}CHEMICAL REVIEWS,1998,(05):1829-1874.
  • 4Anzai K,Kono H,Mizoguchi J. Two-dimensional 13C-1H heteronuclear correlation NMR spectroscopic studies for the inclusion complex of cyclomaltoheptaose(β-cyclodextrin)with a new helicobacter pylori eradicating agent in the amorphous state[J].{H}Carbohydrate Research,2006,(04):499-506.
  • 5Szejtli J. Cylodextrin in drug formulations Part I[J].Pharm Technol Int,1991.15-23.
  • 6Labenz J,B?rsch G. Evidence for the essential role of Helicobacter pylori in gastric ulcer disease[J].{H}GUT,1994.19-22.
  • 7Nomura A,Stemmermann G N,Chyou P H. Helicobacter pylori infection and the risk for duodenal and gastric ulcer-ation[J].{H}ANNALS OF INTERNAL MEDICINE,1994,(12):977-981.
  • 8Nakano T,Inoue H,Fukuyama S. Niflumic acid suppresses interleukin-13-induced asthma phenotypes[J].{H}American Journal of Respiratory and Critical Care Medicine,2006,(11):1216-1221.
  • 9Kim S H,Kim S A,Park M K. Paconol inhibits anaphylactic reaction by regulating histamine and TNF-α[J].Int Immuno-pharmacol,2004,(02):279-287.
  • 10Wu X A,Chen H L,Chen X G. Determination of paeonol in rat plasma by high-performance liquid chromatography and its application to pharmacokinetic studies following oral administration of Moutan cortex decoction[J].Biomed Chro-matogr,2003.504-508.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部